However, several studies suggest that tumor-induced osteomalacia is the most common acquired cause of FGF23-induced hypophosphatemia, has a medium onset age of 40–45 years, and affects both genders equally [4]. The gene discussed is FGF23; the disease is hypophosphatemia.